If your email program has trouble displaying this email, view as a webpage. Recently Posted Guidance Documents 8/26/2022 - E11A Pediatric Extrapolation 8/26/2022 - M12 Drug Interaction Studies 8/26/2022 - Q14 Analytical Procedure Development 8/26/2022 - Q2(R2) Validation of Analytical Procedures 8/26/2022 - E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential--Questions and Answers : Guidance for Industry 8/23/2022 - Tobacco Products: Principles for Designing and Conducting Tobacco Product Perception and Intention Studies 8/23/2022 - Charging for Investigational Drugs Under an IND: Questions and Answers Guidance Document Search Search all FDA official guidance documents and other regulatory guidance

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA